Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Markopoulos

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Anti-Cancer Drugs|August 13, 2005
Effect of exemestane on the lipidemic profile of post-menopausal operable breast cancer patients following 5-7 years of adjuvant tamoxifen: preliminary results of the ATENA substudyC Markopoulos, M Chrissochou, A Michailidou, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1993
Expression of alpha-thymosins in human tissues in normal and abnormal growthO E Tsitsiloni, J Stiakakis, A Koutselinis, et al.
Molecular Medicine (Cambridge, Mass.)|February 17, 1999
Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomasV G Gorgoulis, E N Koutroumbi, A Kotsinas, et al.
Clinical Genetics|March 1, 2005
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological dataA Kataki, Ip Gomatos, N Pararas, et al.
Journal of Chemotherapy (Florence, Italy)|March 5, 2004
Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II studyA Polyzos, N Tsavaris, C Kosmas, et al.
Anticancer Research|June 29, 2007
Breast cancer risk in relation to most prevalent IgE specific antibodies: a case control study in GreeceE T Petridou, C Chavelas, S K Dikalioti, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, P Kosmidis, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, C Markopoulos, et al.
Anticancer Research|July 23, 1998
The prognostic value of alpha-thymosins in breast cancerO E Tsitsilonis, E Bekris, I F Voutsas, et al.
Breast (Edinburgh, Scotland)|May 24, 2016
Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast SurgeonsC Markopoulos, D Koukouras, V Venizelos, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|August 13, 2005
Effect of exemestane on the lipidemic profile of post-menopausal operable breast cancer patients following 5-7 years of adjuvant tamoxifen: preliminary results of the ATENA substudyC Markopoulos, M Chrissochou, A Michailidou, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1993
Expression of alpha-thymosins in human tissues in normal and abnormal growthO E Tsitsiloni, J Stiakakis, A Koutselinis, et al.
Molecular Medicine (Cambridge, Mass.)|February 17, 1999
Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomasV G Gorgoulis, E N Koutroumbi, A Kotsinas, et al.
Clinical Genetics|March 1, 2005
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological dataA Kataki, Ip Gomatos, N Pararas, et al.
Journal of Chemotherapy (Florence, Italy)|March 5, 2004
Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II studyA Polyzos, N Tsavaris, C Kosmas, et al.
Anticancer Research|June 29, 2007
Breast cancer risk in relation to most prevalent IgE specific antibodies: a case control study in GreeceE T Petridou, C Chavelas, S K Dikalioti, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, P Kosmidis, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancerA Onyenadum, H Gogas, C Markopoulos, et al.
Anticancer Research|July 23, 1998
The prognostic value of alpha-thymosins in breast cancerO E Tsitsilonis, E Bekris, I F Voutsas, et al.
Breast (Edinburgh, Scotland)|May 24, 2016
Impact of chemotherapy followed by aromatase inhibitors on bone health of women with ER-positive early breast cancer in real world clinical settings in Greece: Results of the POCHARBI trial conducted by the Hellenic Society of Breast SurgeonsC Markopoulos, D Koukouras, V Venizelos, et al.
Pageof 9